Labelling: control and radiopharmacological evaluation of 99mTc-adenisine 5'-diphosphate(99mTc-ADP) as tumour seeking agent.

Dublin Core

Título

Labelling: control and radiopharmacological evaluation of 99mTc-adenisine 5'-diphosphate(99mTc-ADP) as tumour seeking agent.

Tema

MARCADORES
TECNECIO
RADIOFARMACOS
DETECCION DE TUMORES
AGENTE TUMORAL
BIBLIOGRAFIA NACIONAL
1996

Abstract

A study of 99mTc-adenosine-5'-diphosphate (99mTc-ADP) as a radiopharmaceutical for tumour diagnosis is presented. Two different labelling methods, using SnCl2 in alkaline solution and Zn as reducing agents, were developed. Reduction with Sn(II) alkaline solution was the selected method because a lower concentration of ADP (0.5 mg/mL) could be used and a higher radiochemical yield was achieved. A labelled molecule with a radiochemical purity higher than 95%, in vitro stability of at least 6 hours and an over all negative charge was obtained Biodistribution studies carried out in normal mice and rats revealed rapid urinary excretion and no specific accumulation of activity in any other particular organ. This behaviour was similar to that reported for 99mTc-adenosine-5'-triphosphate (99mTc-ATP). Rapid blood clearance, that could be fitted to a bicompartimental model, was also verified. No evidence of in vivo instability was observed. Studies in mice and rats bearing spontaneous mammary adenocarcinomas were performed and the results were compared to those from the 99mTc-ATP studies. Although the tumour models used were not the same, the incorporation of both labelled compounds was very similar. Radioactivity uptake in the tumour and the tumour-to-blood ratio were not notably high. However, a significant increment was observed in the tumour-to-muscle ratio (1.0 +/- 0.2 at 30 minutes to 2.7 +/- 0.4 at 240 minutes). Whole-body autoradiography enabled tumour visualization. Further investigations, including scintigraphic imaging, must be carried to complete the clinical evaluation of 99mTc-ADP as a tumour seeking agent.

Autor

León, A.
Rey, A.M.
Savio, E.
Kremer, Carlos.
Lacava, C.J.
Nappa, A.N.
Chiozzone, R.
Campos, E.
Savio, E.

Fuente

The Quarterly Journal of Nuclear Medicine v. 40, no. 2, 1996. -- p. 170-5

Fecha

2024

Derechos

Información sobre Derechos de Autor

(Por favor lea este aviso antes de abrir los documentos u objetos)

La legislación uruguaya protege el derecho de autor sobre toda creación literaria, científica o artística, tanto en lo que tiene que ver con sus derechos morales, como en lo referente a los derechos patrimoniales con sujeción a lo establecido por el derecho común y las siguientes leyes (LEY 9.739 DE 17 DE DICIEMBRE DE 1937 SOBRE PROPIEDAD LITERARIA Y ARTISTICA CON LAS MODIFICACIONES INTRODUCIDAS POR LA LEY DE DERECHO DE AUTOR Y DERECHOS CONEXOS No. 17.616 DE 10 DE ENERO DE 2003, LEY 17.805 DE 26 DE AGOSTO DE 2004, LEY 18.046 DE 24 DE OCTUBRE DE 2006 LEY 18.046 DE 24 DE OCTUBRE DE 2006)

ADVERTENCIA - La consulta de este documento queda condicionada a la aceptación de las siguientes condiciones de uso: Este documento es únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con fines de lucro. Esta reserva de derechos afecta tanto los datos del documento como a sus contenidos. En la utilización o cita de partes debe indicarse el nombre de la persona autora.

Formato

PDF

Extent

6 p.

Idioma

Inglés

Tipo

Artículo

Document Item Type Metadata

Original Format

PDF
Fecha de agregación
May 17, 2024
Colección
Bibliografía Nacional Química
Tipo de Elemento
Document
Etiquetas
, , , ,
Citación
León, A., “Labelling: control and radiopharmacological evaluation of 99mTc-adenisine 5'-diphosphate(99mTc-ADP) as tumour seeking agent.,” RIQUIM - Repositorio Institucional de la Facultad de Química - UdelaR, accessed June 15, 2024, https://riquim.fq.edu.uy/items/show/6791.
Archivos